Thai FDA Publishes Standards Information for Strip-Test IVD Devices Image

Thai FDA Publishes Standards Information for Strip-Test IVD Devices

Date
19 Nov 2026

Reference source : Food and Drug Administration

 

Thailand’s Food and Drug Administration, through its Medical Device Control Division, published technical information on 9 November 2026 identifying regulatory instruments and standards relevant to strip-format in vitro diagnostic medical devices.

The publication should be treated as an official technical-information update. The accessible FDA material does not state that a new binding regulation was adopted on 9 November or establish a new general compliance deadline for strip-test products.

Regulatory and Standards Scope

The FDA information refers to Thailand’s Medical Device Act and ministerial notifications governing products such as HIV screening kits, external diagnostic reagents, IVD standards and manufacturing quality systems.

The referenced international standards address several parts of the product lifecycle. These include ISO 13485 for medical-device quality management systems, ISO 14971 for risk management, ISO 23640 for stability evaluation and the ISO 18113 series for information supplied by manufacturers of IVD products.

Other references address clinical performance studies, metrological traceability, self-testing, point-of-care testing and usability engineering. The publication also identifies Clinical and Laboratory Standards Institute documents concerning precision, method comparison, qualitative test performance, detection capability, interference and product stability.

Practical Compliance Considerations

Manufacturers and Thai importers should compare the listed standards with the evidence in their existing registration and conformity-assessment files. Relevant documentation may include analytical and clinical performance studies, stability data, risk-management records, labelling, instructions for use, usability evidence and quality-system documentation.

The FDA page does not establish that every cited standard applies identically to every strip-format IVD. Applicability may depend on the analyte, intended use, professional or self-testing status, risk classification and technical design of the product.

Companies should therefore use the publication as a regulatory review checklist and confirm product-specific requirements with the Thai FDA before treating a particular standard as mandatory or assuming that existing registration documentation must be amended.

 


ACF GHS Report